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Abstract: Quaternary ammonium amphiphiles are a class of compounds with a wide range
of commercial and industrial uses. In the pharmaceutical field, the most common quaternary
ammonium surfactant is benzalkonium chloride (BAC), which is employed as a preservative in
several topical formulations for ocular, skin, or nasal application. Despite the broad antimicrobial
activity against Gram-positive and Gram-negative bacteria, as well as fungi and small enveloped
viruses, safety concerns regarding its irritant and cytotoxic effect on epithelial cells still remain. In this
work, quaternary ammonium derivatives of leucine esters (C10, C12 and C14) were synthesised as
BAC analogues. These cationic surfactants were characterised in terms of critical micelle concentration
(CMC, by tensiometry), cytotoxicity (MTS and LDH assays on the Caco-2 and Calu-3 cell lines) and
antimicrobial activity on the bacterial species Staphylococcus aureus and Enterococcus faecalis among
the Gram-positives, Escherichia coli and Pseudomonas aeruginosa among the Gram-negatives and the
yeast Candida albicans. They showed satisfactory surface-active properties, and a cytotoxic effect that
was dependent on the length of the hydrophobic chain. Lower minimum inhibiting concentration
(MIC) values were calculated for C14-derivatives, which were comparable to those calculated for
BAC toward Gram-positive bacteria and slightly higher for Gram-negative bacteria and C. albicans.
Thus, the synthesised leucine-based quaternary ammonium cationic surfactants can potentially find
application as promising surface-active compounds with antimicrobial activity.
Keywords: cationic surfactants; amino acid; surface tension; antibacterial activity; toxicological studies
1. Introduction
Amino-acid-based surfactants are a promising class of amphiphiles obtained by the condensation
of an amino acid as a polar head and one or two acyl/alkyl chains as hydrophobic tails [1].
These materials are occasionally referred to as “green surfactants”, since they are environmentally
friendly and can be produced according to the principles of green chemistry starting from renewable
materials [2]. The physicochemical properties of these amphiphiles can be tuned by varying
the nature of the amino acid, the number of acyl/alkyl chains and the type of linkage (amide,
ester or alkyl) between the amino acid and the hydrophobic portion, giving a large variety of
linear (single-chain), double-chain or dimeric (gemini) surfactants [3]. According to the site of the
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introduction of the hydrophobic tail on the amino acid functional groups (carboxylic or amine)
and the charge of the amino acid side chain, anionic, cationic and zwitterionic amphiphiles can be
obtained. Both anionic and cationic amino-acid-based surfactants have been widely investigated and
proposed in pharmaceutical and cosmetics formulations as alternatives to commercial surfactants due
to their favourable physicochemical properties (e.g., foamability and emulsification) and toxicological
profiles [4]. Generally, they are considered to be biocompatible and biodegradable, with studies having
confirmed their low toxicity on selected cell lines [5–7]. Cationic-based amphiphiles of this class of
materials have been explored extensively for their antimicrobial activity toward both bacteria and
fungi [8]. To this end, different arginine-, lysine- or histidine-based single chain or dimeric surfactants
have been developed [9–11]. All these compounds have exhibited a wide spectrum of action and
showed a better inhibitory activity against Gram-positive bacteria than Gram-negative bacteria and
fungi, which depends mainly on the length of the hydrocarbon chain in addition to the nature of the
amino acid residue. The best activity was observed for C12/C14 derivatives as a result of an optimal
hydrophobic/hydrophilic balance that enhanced the interaction and penetration of the surfactant
inside the membrane of the micro-organism [9,12]. Quaternary ammonium cationic amphiphiles
can also be obtained from amino acids via alkylation of the amine group. These compounds have
not been fully investigated in terms of their physicochemical and biological properties. Indeed,
the formation of quaternary ammonium salts is an established strategy for obtaining antimicrobial
compounds that has already been explored for other new classes of amphiphiles [13]. In a previous
paper, we synthesised and characterised the surface activity, cytotoxicity, and antimicrobial properties
of two series of linear quaternary ammonium compounds, based on the amino acid leucine and
methionine and with different hydrophobic chain lengths (C10, C12 and C14). These amphiphiles,
especially derivatives with a C12 and C14 hydrocarbon chain, showed a satisfactory cytotoxicity and
an antibacterial profile that was comparable to benzalkonium chloride (BAC), with higher activity
observed against Gram-positive bacteria [14]. In the present work, we report the synthesis of the same
series of leucine-based surfactants by introducing an N-benzyl group, which is a common substituent of
commercial quaternary ammonium compounds (e.g., benzalkonium chloride). Then, we investigated
the surface properties, cytotoxicity and antimicrobial activity of these novel materials.
2. Materials and Methods
2.1. Materials
l-leucine (LEU), 1-decanol, p-toluenesulfonic acid (p-TSA), toluene anhydrous (99.8%),
benzaldehyde, sodium cyanoborohydride and iodomethane purum ≥99.0% were purchased
from Sigma-Aldrich (Milan, Italy). 1-dodecanol and 1-tetradecanol were obtained from DPI
(Lancaster, SC, USA) and sodium carbonate and potassium carbonate from Carlo Erba (Milan,
Italy). All used solvents (acetone, ethyl acetate, diethyl ether and methanol) were of analytical
grade. Benzalkonium chloride (BAC, purity ≥95.0%), composed of benzyldimethyldodecylammonium
chloride (~70%) and benzyldimethyltetradecylammonium chloride (~30%) (from the HPLC
area% according to the manufacturer’s specifications, average molecular weight 348.41 Da)
was purchased from Sigma-Aldrich (Milan, Italy). Dulbecco’s Modified Eagle Medium
(DMEM), foetal bovine serum (FBS), antibiotic/antimycotic solution (10–12,000 U/mL penicillin,
10–12 mg/mL streptomycin, 25–30 µg/mL amphotericin B) and trypsin–EDTA solution (2.5 mg/mL
trypsin, 0.2 mg/mL EDTA) were obtained from Sigma-Aldrich (Poole, UK). The MTS
reagent 3-(4,5-dimethylthiazol-2-yl)-5(3-carboxymethonyphenol)-2-(4-sulphophenyl)-2H-tetrazolium
(CellTiter96® AQueous One Solution Cell Proliferation Assay) was purchased from Promega (Madison,
WI, USA). A PierceTM LDH assay kit was purchased from ThermoScientific (Waltham, MA, USA).
Tissue culture flasks (75 cm3 with ventilated caps) were purchased from Costar. Ultrapure water was
obtained with a laboratory deionizer (Osmo lab UPW2, Gamma 3, (Castelverde, Italy).
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2.2. Methods
2.2.1. Synthesis and Chemical Characterisation of Benzyl Quaternary Ammonium
Leucine-Based Surfactants
The benzyldimethyl ammonium salts of l-leucine, esterified with fatty acids of different lengths
(C10, C12 and C14), were prepared using three steps. The esterification of leucine with the corresponding
alcohol gave the O-acyl leucine derivatives. Subsequently, the benzyl-substituted secondary amine
was prepared by reductive amination (imine formation and reduction). Finally, the quaternary
ammonium salts were obtained by methylation of the N-benzyl secondary amine of the O-acyl amino
acid. The overall synthetic approach is reported in Scheme 1.
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collected, dried with anhydrous sodium sulfate, filtered and the solvent evaporated under vacuum,
yielding a colourless oil [17].
Synthesis of N,N,N-Benzyldimethyl-O-Acyl Leucine Derivatives
K2CO3 (molar ratio 1:3) and CH3I (molar ratio 1:3) were added dropwise to a solution of the
synthesised N-benzyl-O-acyl leucines in acetone (100 mL). The mixture was stirred for 24 h at room
temperature, then cooled down to 4 ◦C and filtered to remove K2CO3. After evaporation of the organic
solvent under vacuum, the quaternary ammonium salt was separated from the crude product by
precipitation in ethyl ether. Finally, the crude solid was purified by repeated crystallisation from
ethanol [18].
Chemical identification of the surfactants was performed by 1H-NMR (Varian EM-400 MHz
spectrometer, Palo Alto, CA, USA) using deuterated DMSO as a solvent. Chemical structures,
relative abbreviations and identification of the 1H-NMR signals for all synthesised surfactants are
reported in the Supplementary Materials (Table S1).
2.2.2. Surface Tension Measurements
Different concentrations for each surfactant were prepared by dissolving the compounds in
ultrapure water. Their ability to decrease air–water surface tension was studied at 25 ◦C using a
DCA-100 tensiometer (First Ten Angstrom, Portsmouth, VA, USA) according to the De Nouy ring
method. Each recorded surface tension value was the mean of three consecutive measurements.
The ‘breakpoint’ of the plot of surface tension versus concentration of surfactant was used to calculate
the critical micelle concentration (CMC, i.e., the minimum concentration at which surfactants aggregate
to form micelles) and the surface tension at CMC (γCMC). The “breakpoint” is the point of intersection
of the two lines fitting the experimental data by a linear regression model (Prism version 5.0, GraphPad
Inc., San Diego, CA, USA). Tensiometric measurements allowed for the calculation of an additional two
parameters related to the surface behaviour of surfactants. The first is the ‘surface excess concentration’,
Γmax, which is a measure of how many surfactant molecules are adsorbed at the air–water interface,
which was calculated using the Gibbs equation:
Γmax =
1
2.303 nRT
(
δγ
δ logC
) (1)
where R is the gas constant (8.314 J/mol K); T is the absolute temperature (K); n is equal to 1 for single
chain ionic surfactants displaying only one ionisable group; and dγ/d log C can be calculated from
the slope of the straight section before the CMC in the plot of surface tension versus concentration of
the surfactant.
The other parameter is the area occupied by a single molecule of surfactant at the water–air
interface (As), and is derived from Γmax through the equation:
Amin =
1018
NΓmax
. (2)
All analyses were performed in triplicate.
2.2.3. Cytotoxicity Studies (MTS and LDH Assays) and Haemolytic Assay
Colorectal-carcinoma-derived epithelial Caco-2 cells (European Collection of Cell Cultures) and
airway epithelial Calu-3 cells (American Type Culture Collection; ATCC) were cultured in DMEM
supplemented with 10% of FBS and 1% of an antibiotic–antimycotic mixture. Erythrocytes were
collected from mice blood. The cytotoxicity of the N-benzyl quaternary ammonium surfactants derived
from leucine in comparison to the commercial BAC was studied by performing two cytotoxicity
assays (MTS and LDH as indicators of metabolic activity and membrane integrity, respectively) and
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by a haemolytic assay. The assays were conducted as reported in our previous publications [5,14].
EC50 values from the MTS assay (concentration of surfactant that causes 50% cell death) and the LDH
assay (concentration of surfactants that causes 50% LDH release from cells), as well as HC50 values
from the haemolytic assay (concentration of surfactants that causes 50% haemoglobin release from
erythrocytes) were calculated using a nonlinear regression model (Prism version 5.0, GraphPad Inc.,
San Diego, CA, USA) as follows:
Y = BOTTOM +
Top− Bottom
1 + 10(LogEC50−x) Hill Slope
(3)
where Top and Bottom are plateaux in the units of the Y axis.
2.2.4. Antimicrobial Assay and MIC Determination
The antimicrobial activity was evaluated against the bacterial and fungal species listed in Table 1.
Bacterial strains were cultured overnight at 35–36 ◦C in blood agar plates. Minimum inhibitory
concentrations (MICs) were determined according to previous reports [14] and following protocols
defined by the European Committee on Antimicrobial Susceptibility Testing (EUCAST). MICs against
Candida albicans were determined using a similar protocol with some adaptations to the yeast growth
and requirements. All tests were done in triplicate.
Table 1. A list of the strains that were used to test the antimicrobial activity of the synthesised quaternary
ammonium surfactants.
Species Strain Note
Staphylococcus aureus ATCC 25923 Gram-positive
Enterococcus faecalis ATCC 29212 Gram-positive
Escherichia coli ATCC 25922 Gram-negative
Pseudomonas aeruginosa ATCC 27853 Gram-negative
Candida albicans ATCC 24433 Fungus, Yeast
3. Results
3.1. Tensiometric Analysis
Figure 1 shows the decrease in surface tension (mN/m) as a function of concentration for the
synthesised quaternary ammonium leucine surfactants and BAC as a comparison. The calculated
CMC values were influenced by the hydrophobicity, which is the length of the hydrocarbon chain.
Particularly, C12 LEU BENZ displayed a CMC comparable to that of BAC (around 1 mM). All the
derivatives had good surface properties, as demonstrated by γCMC and Γmax (Table 2). For C10 LEU
BENZ, γCMC was around 30 mN/m, similarly to BAC, but it increased up to 40 mN/m for the derivatives
with a longer hydrocarbon chain (C12 LEU BENZ and C14 LEU BENZ). Γmax values, indicating the
tendency of the molecules to adsorb at the air–water interface, were in the order of 106 (mol/m2) and
comparable to BAC.
3.2. Cytotoxicity Studies and the Haemolitic Assay
Cytotoxicity on the two selected cell lines, namely intestinal epithelial Caco-2 and airway epithelial
Calu-3 (Figures 2 and 3, respectively) showed a clear dependence on the length of the hydrocarbon
chain for the synthesised surfactants as demonstrated from the calculated EC50 values, which decreased
from C10 to C14 derivatives. These values were at least 10-fold lower than the CMC, and, for the
C12 and C14 derivatives, they were comparable to BAC (Table 2). No notable differences were found
between the two selected cell lines in terms of EC50 with both cytotoxicity assays (MTS and LDH
assays) for all analysed surfactants.
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CMC (mM) γCMC (mN/m) 106 Γmax (mol/m2) Amin (A2)
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Table 3. Cytotoxicity parameters (EC50) and HC50 values of the synthesised quaternary ammonium
leucine surfactants (C10 LEU BENZ, C12 LEU BENZ and C14 LEU BENZ) in comparison to BAC
as determined by MTS, LDH and haemolytic assays. EC50 is the concentration of surfactants that
caused a 50% reduction of viable cells (MTT assay) or a 50% release of LDH (LDH assay). HC50 is the
concentration of surfactants that caused a 50% haemoglobin release from erythrocytes. Results are
mean ± SD of at least three independent repeated experiments.
Surfactant
MTS Assay (EC50 mM) LDH Assay (EC50 mM) Haemolysis
(HC50 mM)Caco-2 Calu-3 Caco-2 Calu-3
BAC 0.033 ± 0.001 0.022 ± 0.005 0.048 ± 0.004 0.029 ± 0.005 0.064 ± 0.004
C10 LEU BENZ 0.160 ± 0.007 0.117 ± 0.005 0.158 ± 0.015 0.187 ± 0.024 0.148 ± 0.018
C12 LEU BENZ 0.016 ± 0.003 0.011 ± 0.002 0.019 ± 0.002 0.019 ± 0.003 0.054 ± 0.004
C14 LEU BENZ 0.013 ± 0.002 0.014 ± 0.002 0.012 ± 0.002 0.014 ± 0.002 0.027 ± 0.006
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3.3. Antimicrobial Assay
The results from the antimicrobial assay in terms of minimum inhibitory concentration (MIC)
are reported in Table 4. Similarly to BAC, all synthesised quaternary ammonium surfactants were
more effective against Gram-positive bacterial species and the fungus C. albicans than Gram-negative
bacteria. The least susceptible bacteria was the Gram-negative Pseudomonas aeruginosa. C14 derivatives
displayed the highest activity against all micro-organisms, especially against Gram-positive bacteria,
and showed MIC values comparable to BAC.
Table 4. Calculated minimum inhibitory concentration (MIC) values (mg/L and µM) for the synthesised
quaternary ammonium leucine surfactants (C10 LEU BENZ, C12 LEU BENZ and C14 LEU BENZ) and
the reference compound BAC.
Surfactant
MIC Values
S. aureus E. faecalis E. coli P. aeruginosa C. albicans
mg/L µM mg/L µM mg/L µM mg/L µM mg/L µM
BAC 1 2.9 1 2.9 4 11.5 32 91.8 4 11.5
C10 LEU BENZ 2 3.8 4 7.7 64 123.7 >128 >247.5 64 123.7
C12 LEU BENZ 4–8 10.6 4–8 10.6 32 58.6 128 234.6 16 29.3
C14 LEU BENZ 1–2 2.6 2 3.5 16 27.9 128 223.1 8 13.9
A comparison between MICs of leucine-based quaternary ammonium surfactants with and without
(values are reported in [14]) the N-benzyl group may indicate the contribution of this substituent to the
antimicrobial activity. Overall, the antimicrobial activity is negatively affected by the introduction of
the N-benzyl group, as is evident for the C12 and C14 derivatives. Conversely, an enhanced effect
by the presence of the benzyl group was observed in the case of the C10 derivative against the two
Gram-positive bacterial species Staphylococcus aureus and Enterococcus faecalis (Figure 5).
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The different effect exerted by the introduction of the N-benzyl group also affects the selectivity
index (EC50/MIC), which can be considered as a parameter indicating the relationship between the
effectiveness and safety of the surfactants. Indeed, selectivity indexes higher than 10 were calculated
only for C10 LEU BENZ against the two tested Gram-positive bacteria, indicating a possible selective
antimicrobial effect at non-cytotoxic concentrations (Table S2).
4. Discussion
Research regarding surfactants is increasingly focused on the synthesis and discovery of
amphiphilic molecules showing good surface adsorption properties, together with additional biological
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activities. Among these, one of the most explored is the antimicrobial activity, which is characteristic
of cationic surfactants, including quaternary ammonium compounds [19,20]. Indeed, quaternary
ammonium amphiphiles are well-known for their antibacterial (especially toward Gram-positive)
and antifungal activities, which is why they are available as marketed products for a wide range of
applications, including pharmaceuticals and cosmetics. Different modifications have been proposed to
enhance the antimicrobial activity of these amphiphiles, including addition of alkyl or benzyl groups
and different aromatic moieties [21,22]. The modification by the addition of N-benzyl groups is quite
common and these surfactants are present in many of the commercial products (e.g., benzalkonium
chloride) as disinfectants or biocides [23].
In terms of adsorption properties and lowering of surface tension, the substitution of a methyl
group with a benzyl group exerts a double effect by increasing the hydrophobicity and the steric
hindrance of the ammonium quaternary polar head. Indeed, leucine-based surfactants in the presence
of the N-benzyl group have CMC values lower than the corresponding N-methylated compounds
due to the higher hydrophobicity. Moreover, only C10 N-benzyl surfactants maintained γCMC values
around 30 mN/m, similarly to all N-methylated compounds, while, for the C12 and C14 N-benzyl
derivatives, the γCMC values increased up to 40 mN/m, probably due to the combined effect of a larger
size of the polar head and the longer hydrophobic tail.
Cytotoxicity studies with these materials were performed on two cell lines relevant to the oral
(Caco-2) and respiratory (Calu-3) route of administration. The data showed a clear link between the
EC50 values and CMC, similarly to N-methylated compounds and other classes of surfactants [6,24,25].
Slightly lower EC50 values were calculated for the C12 and C14 derivatives of N-benzyl surfactants,
while, for the C10 derivatives, these values were comparable to the counterpart N-methylated
compound. A clear relationship between EC50 and the other surface parameters (Γmax and Amin) was
not found, suggesting that CMC is the most sensitive physicochemical property affecting cytotoxicity.
The synthesised surfactants containing theN-benzyl group displayed a wide range of antimicrobial
activity against Gram-positive and Gram-negative bacteria, as well as fungi. Despite the large number
of modifications performed on the quaternary ammonium group reported in the literature for
antimicrobials, it is not straightforward to perform a direct comparison between the antimicrobial
activity of the same compound before and after the addition of a benzyl group. It is known that
the antimicrobial activity of quaternary ammonium salts depends on the irreversible binding to the
phospholipids and proteins of the membrane, thereby impairing permeability [19,26]. Specifically,
the different nature of the N-substituent affects the hydrophobicity of the compounds and their ability
to adsorb onto the micro-organism surface, as well as the ability of the molecules to be inserted inside
the membrane. For instance, with isatin, an indole derivative, the introduction of a benzyl group
decreased the activity against Gram-negative bacteria and enhanced the activity against Gram-positive
bacteria [27]. On the other hand, the more lipophilic imidazolium salts, in which the quaternary
ammonium is directly linked to a benzyl group, showed a lower antimicrobial activity than the more
hydrophilic analogs [28]. In the case of the synthesised leucine-based surfactant series, the introduction
of the benzyl group has exerted an opposite effect in terms of antimicrobial activity. An enhanced
inhibition of growth was observed only for the C10 derivative against Gram-positive bacteria, while in
the other cases (the C12 and C14 derivatives as well as C10 against the Gram-negatives and C. albicans),
there was a decrease in activity since higher MIC values were obtained. This result can be explained
by the increased hydrophobicity of the compounds leading to an effective insertion of the surfactant
inside the membrane in the case of the shortest derivative (C10).
5. Conclusions
The synthesised leucine-based quaternary ammonium surfactants N-functionalised with a benzyl
group showed good surface properties and a toxicological profile comparable to BAC as a reference
compound. Moreover, they maintained the wide antimicrobial spectrum of activity of all quaternary
ammonium compounds, being highly effective in terms of MIC toward the Gram-positive bacteria.
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The results also highlighted the different effects exerted by the presence of the N-benzyl group on
the selectivity among the different tested micro-organisms and in relation to the different length of
the hydrocarbon chain of the amphiphiles. Indeed, the antimicrobial activity was enhanced only for
the N-benzyl C10 derivative toward Gram-positive bacteria, which may be related to an effective
adsorption of this surfactant and insertion of its hydrophobic chain inside the bacterial membrane.
Supplementary Materials: The following are available online at http://www.mdpi.com/1999-4923/11/6/287/s1,
Table S1: Chemical structures and H1-NMR interpretation for benzyl quaternary ammonium leucine-based
surfactants. Table S2: Selectivity index (EC50/MIC) for the synthesised leucine-based quaternary ammonium
surfactants in comparison to BAC. EC50 values are from the MTS assay.
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